Literature DB >> 6324459

Mouse mammary tumor virus can mediate cell fusion at reduced pH.

S Redmond, G Peters, C Dickson.   

Abstract

Mouse mammary tumor virus, a type-B retrovirus, was shown to mediate fusion of cultured cells following low-pH treatment. Fusion could be demonstrated both with virus-infected cells or with uninfected cells carrying freshly absorbed virus. Although the fusion response was variable between different cell lines, one line of MMTV-infected mink lung cells, designated MGR4, was particularly susceptible to fusion at reduced pH. Since expression of MMTV in these cells is strongly regulated by glucocorticoids, it was possible to demonstrate that cell fusion was dependent on MMTV-encoded functions. With MGR4 cells, a pH threshold for membrane fusion was observed, centered on pH 5.5, at which 50% of the cells were fused. At lower pHs virtually all of the cells in the monolayer fused. These results are similar to those described for other virus groups and are consistent with the idea that most enveloped animal viruses infect cells by a common mechanism involving membrane fusion triggered by low pH.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6324459     DOI: 10.1016/0042-6822(84)90405-7

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  34 in total

1.  Foamy virus envelope glycoprotein-mediated entry involves a pH-dependent fusion process.

Authors:  Marcus Picard-Maureau; Gergely Jarmy; Angelika Berg; Axel Rethwilm; Dirk Lindemann
Journal:  J Virol       Date:  2003-04       Impact factor: 5.103

2.  A versatile and potentially general approach to the targeting of specific cell types by retroviruses: application to the infection of human cells by means of major histocompatibility complex class I and class II antigens by mouse ecotropic murine leukemia virus-derived viruses.

Authors:  P Roux; P Jeanteur; M Piechaczyk
Journal:  Proc Natl Acad Sci U S A       Date:  1989-12       Impact factor: 11.205

3.  Mechanism of entry of a xenotropic MMuLV-derived recombinant retrovirus into porcine cells using the expression of the reporter nlslacZ gene.

Authors:  M A Gilbert; B Charreau; P Vicart; D Paulin; P K Nandi
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

4.  Requirements for different components of the host cell cytoskeleton distinguish ecotropic murine leukemia virus entry via endocytosis from entry via surface fusion.

Authors:  K Kizhatil; L M Albritton
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

5.  Exceptional fusogenicity of Chinese hamster ovary cells with murine retroviruses suggests roles for cellular factor(s) and receptor clusters in the membrane fusion process.

Authors:  D C Siess; S L Kozak; D Kabat
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

6.  Properties of the naturally occurring soluble surface glycoprotein of ecotropic murine leukemia virus: binding specificity and possible conformational change after binding to receptor.

Authors:  H Ikeda; K Kato; T Suzuki; H Kitani; Y Matsubara; S Takase-Yoden; R Watanabe; M Kitagawa; S Aizawa
Journal:  J Virol       Date:  2000-02       Impact factor: 5.103

7.  Mass action kinetics of virus-cell aggregation and fusion.

Authors:  J Bentz; S Nir; D G Covell
Journal:  Biophys J       Date:  1988-09       Impact factor: 4.033

8.  Role of protein N-glycosylation in pathogenesis of human immunodeficiency virus type 1.

Authors:  D C Montefiori; W E Robinson; W M Mitchell
Journal:  Proc Natl Acad Sci U S A       Date:  1988-12       Impact factor: 11.205

9.  Identification of the receptor binding domain of the mouse mammary tumor virus envelope protein.

Authors:  Yuanming Zhang; John C Rassa; Maria Elena deObaldia; Lorraine M Albritton; Susan R Ross
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

10.  Analysis of the murine ecotropic leukemia virus receptor reveals a common biochemical determinant on diverse cell surface receptors that is essential to retrovirus entry.

Authors:  S Malhotra; A G Scott; T Zavorotinskaya; L M Albritton
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.